Vincent Leymarie
- Hematology top 10%
- Immunology
- Molecular Biology
- Public Health, Environmental and Occupational Health
- Oncology
- Co-authors
- Seiamak BahramM. ArdizzoneJean SibiliaCatherine HéliasM LessardA. FalkenrodtStéphanie StruskiLaurent Mauvieux
- Topics
- Acute Myeloid Leukemia Research (5 papers)Chronic Lymphocytic Leukemia Research (5 papers)Chronic Myeloid Leukemia Treatments (5 papers)
- Cited by
- HematologyImmunologyGenetics
- Partner nations
- FranceUnited Kingdom
In The Last Decade
Vincent Leymarie
15 papers receiving 222 citations
Peers
Comparison fields: 5 of 40
- Hematology 95
- Immunology 88
- Molecular Biology 56
- Public Health, Environmental and Occupational Health 52
- Oncology 40
Countries citing papers authored by Vincent Leymarie
This map shows the geographic impact of Vincent Leymarie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Leymarie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Leymarie more than expected).
Fields of papers citing papers by Vincent Leymarie
This network shows the impact of papers produced by Vincent Leymarie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Leymarie. The network helps show where Vincent Leymarie may publish in the future.
Co-authorship network of co-authors of Vincent Leymarie
This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Leymarie. A scholar is included among the top collaborators of Vincent Leymarie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Leymarie. Vincent Leymarie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 77 | |
| 4 | 3 | |
| 5 | 25 | |
| 6 | 15 | |
| 7 | 2 | |
| 8 | 31 | |
| 9 | [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification]. | 3 |
| 10 | 2 | |
| 11 | 0 | |
| 12 | 2 | |
| 13 | 25 | |
| 14 | 32 | |
| 15 | 3 | |
| 16 | Leucémie myéloïde chronique avec monocytose exprimant des transcrits BCR-ABL du type e1 a2 : un nouveau syndrome myéloprolifératif ? | 1 |
About Vincent Leymarie
Vincent Leymarie is a scholar working on Hematology, Genetics and Family Practice, having authored 16 papers that have together received 226 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Hematology (95 citations), Immunology (88 citations) and Genetics (37 citations). Vincent Leymarie has collaborated with scholars based in France and United Kingdom. Frequent co-authors include Seiamak Bahram, M. Ardizzone, Jean Sibilia, Catherine Hélias, M Lessard, A. Falkenrodt, Stéphanie Struski, Laurent Mauvieux, P Lutz and Bruno Lioure. Their work appears in journals such as Blood, PLoS ONE and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.